Drug name - Colcrys

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8093296 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics Oct, 2028

(6 years from now)

US7964648 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Oct, 2028

(6 years from now)

US7981938 TAKEDA PHARMS USA Colchicine compositions and methods Oct, 2028

(6 years from now)

US7964647 TAKEDA PHARMS USA Colchicine compositions and methods Oct, 2028

(6 years from now)

US8093297 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Oct, 2028

(6 years from now)

US8097655 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics Oct, 2028

(6 years from now)

US8415396 TAKEDA PHARMS USA Colchine compositions and methods Oct, 2028

(6 years from now)

US8415395 TAKEDA PHARMS USA Colchicine compositions and methods Oct, 2028

(6 years from now)

US8093298 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics Oct, 2028

(6 years from now)

US7619004 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics Dec, 2028

(6 years from now)

US7935731 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics Dec, 2028

(6 years from now)

US7601758 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares Feb, 2029

(6 years from now)

US7906519 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Feb, 2029

(6 years from now)

US8440722 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Feb, 2029

(6 years from now)

US8440721 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Feb, 2029

(6 years from now)

US7915269 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Feb, 2029

(6 years from now)

US7820681 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent Feb, 2029

(6 years from now)

Drugs and Companies using COLCHICINE ingredient

Treatment: Method of treating gout flares; For the treatment and prophylaxis of gout flares & the treatment of familial mediterranean fever; A method for treatment of gout flares during prophylaxis; Method of using colchicine for the prophylaxis of gout flares; Method of administering colchicine to familial mediterranean fever patients

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.6MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.